CatalYm today announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage ...

According to a new comprehensive report from The Insight Partners, the global enterprise IP management software market share is observing healthy growth owing to the adoption and integration of ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that the US Food & Drug ...